Virus therapy shows promise for aggressive brain cancer
NCT ID NCT07126990
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This study tests a new oncolytic virus (Ad-TD-nsIL12) in 40 adults with high-grade glioma, a fast-growing brain tumor. The virus is designed to infect and kill cancer cells while boosting the immune system. The main goal is to see how many patients survive for at least 12 months after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sanbo Brain Hospital, Capital Medical University
Beijing, Chaoyang District, China
Conditions
Explore the condition pages connected to this study.